Overall survival of perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in locally advanced gastric or gastrooesophageal junction adenocarcinoma undergoing D2 gastrectomy: An updated analysis of RESOLVE trial

被引：10

作者：

Zhang, X. ^{[1
]}

Li, Z. ^{[2
]}

Liang, H. ^{[3
]}

Xue, Y. ^{[4
]}

Wang, Y. ^{[5
]}

Zhou, Z. ^{[6
]}

Yu, J. ^{[7
]}

Chen, L. ^{[8
]}

Du, Y. ^{[9
]}

Li, G. ^{[10
]}

Xiao, G. ^{[11
]}

Wu, D. ^{[12
]}

Zhou, Y. ^{[13
]}

Dang, C. ^{[14
]}

He, Y. ^{[15
]}

Zhang, Z. ^{[16
]}

Sun, Y. ^{[17
]}

Li, Y. ^{[18
]}

Shen, L. ^{[1
]}

Ji, J. ^{[2
]}

机构：

[1] Peking Univ Canc Hosp, Dept Gastrointestinal Oncol, Beijing Canc Hosp, Beijing, Peoples R China

[2] Peking Univ Canc Hosp, Gastrointestinal Canc Ctr, Beijing Canc Hosp, Beijing, Peoples R China

[3] Tianjin Med Univ Canc Inst & Hosp, Dept Surg, Tianjin, Peoples R China

[4] Harbin Med Univ, Dept Surg, Canc Hosp, Harbin, Peoples R China

[5] Fudan Univ, Dept Surg, Shanghai Canc Ctr, Shanghai, Peoples R China

[6] Sun Yat Sen Univ, Dept Surg, Canc Ctr, Guangzhou, Peoples R China

[7] Zhejiang Univ, Affiliated Hosp 1, Dept Surg, Sch Med, Hangzhou, Peoples R China

[8] Chinese Peoples Liberat Army Gen Hosp, Dept Surg, Mil Hosp 301, Beijing, Peoples R China

[9] Zhejiang Canc Hosp, Dept Surg, Hangzhou, Peoples R China

[10] East Theater Gen Hosp PLA, Dept Surg, Nanjing, Peoples R China

[11] Beijing Hosp, Dept Surg, Beijing, Peoples R China

[12] Zhejiang Univ, Dept Surg, Affiliated Hosp 2, Sch Med, Hangzhou, Peoples R China

[13] Qingdao Univ, Dept Surg, Affiliated Hosp, Qingdao, Shandong, Peoples R China

[14] Xi An Jiao Tong Univ, Dept Surg, Affiliated Hosp 1, Xian, Peoples R China

[15] Sun Yat Sen Univ, Dept Surg, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China

[16] Capital Med Univ, Beijing Friendship Hosp, Dept Surg, Beijing, Peoples R China

[17] Fudan Univ, Dept Surg, Zhongshan Hosp, Shanghai, Peoples R China

[18] Hebei Med Univ, Dept Surg, Hosp 4, Shijiazhuang, Hebei, Peoples R China

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.10.079

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA78

引用

页码：S1318 / S1319

页数：2

共 50 条

[1] Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE) final report of a randomised, open-label, phase 3 trial
Zhang, Xiaotian
Liang, Han
Li, Ziyu
Xue, Yingwei
Wang, Yanong
Zhou, Zhiwei
Yu, Jiren
Bu, Zhaode
Chen, Lin
Du, Yian
Wang, Xinbao
Wu, Aiwen
Li, Guoli
Su, Xiangqian
Xiao, Gang
Cui, Ming
Wu, Dan
Chen, Li
Wu, Xiaojiang
Zhou, Yanbing
Zhang, Lianhai
Dang, Chengxue
He, Yulong
Zhang, Zhongtao
Sun, Yihong
Li, Yong
Chen, Huanqiu
Bai, Yuxian
Wang, Yakun
Yu, Peiwu
Zhu, Guanbao
Suo, Jian
Jia, Baoqing
Li, Leping
Huang, Changming
Li, Fei
Ye, Yingjiang
Xu, Huimian
Wang, Xin
Yuan, Yannan
Jianyu, E.
Ying, Xiangji
Yao, Chen
Shen, Lin
Ji, Jiafu
LANCET ONCOLOGY, 2025, 26 (03): : 312 - 319
[2] Perioperative chemotherapy of oxaliplatin combined with S-1 (SOX) versus postoperative chemotherapy of SOX or oxaliplatin with capecitabine (XELOX) in locally advanced gastric adenocarcinoma with D2 gastrectomy: A randomized phase III trial (RESOLVE trial)
Ji, J.
Shen, L.
Li, Z.
Zhang, X.
Liang, H.
Xue, Y.
Wang, Y.
Zhou, Z.
Yu, J.
Chen, L.
Du, Y.
Li, G.
Xiao, G.
Wu, D.
Zhou, Y.
Dang, C.
He, Y.
Zhang, Z.
Sun, Y.
Li, Y.
ANNALS OF ONCOLOGY, 2019, 30 : 877 - 877
[3] Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial (vol 22, pg 1081, 2021)
Zhang, Xiaotian
Liang, Han
Li, Ziyu
Xue, Yingwei
Wang, Yanong
Zhou, Zhiwei
Yu, Jiren
Bu, Zhaode
Chen, Lin
Du, Yian
Wang, Xinbao
Wu, Aiwen
Li, Guoli
Su, Xiangqian
Xiao, Gang
Cui, Ming
Wu, Dan
Chen, Li
Wu, Xiaojiang
Zhou, Yanbing
Zhang, Lianhai
Dang, Chengxue
He, Yulong
Zhang, Zhongtao
Sun, Yihong
Li, Yong
Chen, Huanqiu
Bai, Yuxian
Qi, Changsong
Yu, Peiwu
Zhu, Guanbao
Suo, Jian
Jia, Baoqing
Li, Leping
Huang, Changming
Li, Fei
Ye, Yingjiang
Xu, Huimian
Wang, Xin
Yuan, Yannan
Jian-Yu, E.
Ying, Xiangji
Yao, Chen
Shen, Lin
Ji, Jiafu
LANCET ONCOLOGY, 2021, 22 (08): : E347 - E347
[4] Perioperative & postoperative oxaliplatin and S-1 (SOX) adjuvant chemotherapy on gastric cancer patients' D2 gastrectomy
Subrata, J. A. K.
Sutanto, R.
Liauw, R.
ANNALS OF ONCOLOGY, 2024, 35 : S1368 - S1368
[5] Comparison of capecitabine and oxaliplatin with S-1 as adjuvant chemotherapy in stage III gastric cancer after D2 gastrectomy
Cho, Jang Ho
Lim, Jae Yun
Cho, Jae Yong
PLOS ONE, 2017, 12 (10):
[6] Survival Outcomes of Two Phase 2 Studies of Adjuvant Chemotherapy with S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Patients with Gastric Cancer After D2 Gastrectomy
Yoshiaki Nakamura
Takeharu Yamanaka
Keisho Chin
Haruhiko Cho
Hitoshi Katai
Masanori Terashima
Kazunari Misawa
Motohiro Hirao
Kazuhiro Yoshida
Eiji Oki
Mitsuru Sasako
Yasunori Emi
Hideaki Bando
Yoshiyuki Kawashima
Tetsu Fukunaga
Masahiro Gotoh
Takako Ishibashi
Kohei Shitara
Annals of Surgical Oncology, 2019, 26 : 465 - 472
[7] Survival Outcomes of Two Phase 2 Studies of Adjuvant Chemotherapy with S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Patients with Gastric Cancer After D2 Gastrectomy
Nakamura, Yoshiaki
Yamanaka, Takeharu
Chin, Keisho
Cho, Haruhiko
Katai, Hitoshi
Terashima, Masanori
Misawa, Kazunari
Hirao, Motohiro
Yoshida, Kazuhiro
Oki, Eiji
Sasako, Mitsuru
Emi, Yasunori
Bando, Hideaki
Kawashima, Yoshiyuki
Fukunaga, Tetsu
Gotoh, Masahiro
Ishibashi, Takako
Shitara, Kohei
ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (02) : 465 - 472
[8] Health-Related Quality of Life in Patients With Locally Advanced Gastric Cancer Undergoing Perioperative or Postoperative Adjuvant S-1 Plus Oxaliplatin With D2 Gastrectomy: A Propensity Score-Matched Cohort Study
Yu, Jianhong
Wang, Zaozao
Li, Zhexuan
Liu, Ying
Fan, Yingcong
Di, Jiabo
Cui, Ming
Xing, Jiadi
Zhang, Chenghai
Yang, Hong
Yao, Zhendan
Zhang, Nan
Chen, Lei
Liu, Maoxing
Xu, Kai
Tan, Fei
Gao, Pin
Su, Xiangqian
FRONTIERS IN ONCOLOGY, 2022, 12
[9] Oxaliplatin plus capecitabine (XELOX) in the perioperative treatment of locally advanced gastric adenocarcinoma in combination with D2 gastrectomy (NEO-CLASSIC).
Liu, Tianshu
Yu, Yiyi
Fang, Yong
Shen, Zhenbin
Yan, Min
Cao, Hui
Liu, Yingbin
Wang, Xuefei
Cui, Yuehong
Wang, Yan
Liu, Fenlin
Chen, Weidong
Li, Wei
Sun, Yihong
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[10] Oxaliplatin plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma in Combination with D2 Gastrectomy: NEO-CLASSIC Study
Yu, Yiyi
Fang, Yong
Shen, Zhenbin
Wang, Yan
Yan, Min
Cao, Hui
Liu, Yingbin
Wang, Xuefei
Cui, Yuehong
Liu, Fenglin
Chen, Weidong
Li, Wei
Li, Qian
Jiang, Huiqin
Sun, Yihong
Liu, Tianshu
ONCOLOGIST, 2019, 24 (10): : 1311 - +

← 1 2 3 4 5 →